EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Xoma AB B (XOM-B) fair value: what the stock is really worth

As of Oct 2, 2026: fair value of Xoma AB B SEK 0.21, price SEK 0.53, upside -60.1%, quality 40 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Consumer Defensive · SE

XA Thin data Oct 4, 2026

Xoma AB B

XOM-B · ST

Weakest SetupStrongly overvalued and low quality.

Quality 40/100
Fair value kr 0.2100 · Strongly overvalued (−60.1%)
Weak Growth (revenue YoY −99.9 %/yr in SEK)
Negative free cash flow
Trails peers (2/8)
Narrow moat 6/100
Thin data
⟳ Cyclical
Watch Xoma AB B for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 2.68 kr 0.2230 Fair Value kr 0.2100 Nov 2024 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.

How to read this chart

22‑month range kr 0.2230 – kr 2.68 · fair‑value band kr 0.1400 – kr 0.2600 · the kr 0.5260 price screens above the kr 0.2100 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 4, 2026.

Follow Xoma AB B in your weekly email

Every Wednesday you see whether Xoma AB B is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Xoma AB (publ) develops and sells algae cultivation and water purification solutions for food security, cosmetics, and pharmaceutical industries. Its principal products are CLAS (closed-loop aquaculture system) and FLOW (filtration of liquids and organic waste). The company was incorporated in 2016 and is headquartered in Gothenburg, Sweden.

Stock analysis

Xoma AB B (XOM-B) currently trades at kr 0.5260, while our model-based Fair Value estimate is kr 0.2100, 60.1% below the price, so the stock looks overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 1 models at a data quality of 92/100, which puts the evidence level at low.

Scenario range: kr 0.1400 (bear) to kr 0.2600 (bull), the price of kr 0.5260 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 40/100 (below-average quality), in the Consumer Defensive sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Xoma AB B reported revenue of 0 SEK in FY2025 versus 0 SEK in FY2022. Reported net income was −9.6M SEK in FY2025.

Key figures

Market cap 55.7M SEK (≈ $5.6M) · P/E ratio 26.1 · P/S ratio 50.6 · EPS (TTM) kr −0.0900 · Return on equity −111% · Return on assets (EBIT) −65.4% · Operating margin −45,061% · Revenue (TTM) 844K SEK.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).

What moves the price

The share trades about 52% below its 52-week high and 136% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at −60%, XOM-B screens richer than that median.

Fair Value models

Bear kr 0.1400 Fair Value kr 0.2100 Bull kr 0.2600
Price kr 0.5260 · Upside -60.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) kr 0.1300 kr 0.1800 kr 0.2700 51
All 1 models by family
Asset-Based
NCAV (Graham) kr 0.1300 kr 0.1800 kr 0.2700 51

Open the full fair value analysis →

Notify me when XOM-B reaches fair value

Put XOM-B on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 40/100

Of which business quality 39 · Market factors (momentum, volatility) 36

Profitability 4
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 28
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 0
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 54
Price trend over the last 3–12 months (market factor)
52W Momentum 46
Distance to the 52-week high (market factor)
Net Issuance 40
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

XOM-B screens overvalued: fair value 60% below the price. Compare with Archer-Daniels-Midland Company →

Compare Xoma AB B with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Farm Products · 290 stocks

Beats the industry median on 2/7 measures
Overall it trails its industry peers.
Valuation
Quality Score 40 · Bottom 25%
Fair Value upside −62.2% · Bottom 25%
Profitability
Return on assets −62.3% · Bottom 25%
Growth and dividend
Revenue growth 726.0% · Top 25%

Valuation Multiplesvs Farm Products median · lower = cheaper

P/E (TTM) 26.1× · Priciest 25%
P/B 0.37× · Cheapest 25%
P/S (TTM) 6.95× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 26
FUTURE (revenue growth)100 · sector 17
PAST (return on equity)0 · sector 19
HEALTH (low debt)0 · sector 94
DIVIDEND (yield)0 · sector 44

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Farm Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Archer-Daniels-Midland Company ADM $80.45 $38.02 −53%
Muyuan Foods Group 002714 ¥40.48 ¥115.35 +185%
Bunge Global SA BG $108.14 $56.75 −48%
Tyson Foods, Inc TSN $50.98 $37.06 −27%
Wens Foodstuff Group 300498 ¥14.51 ¥12.08 −17%
Mowi ASA MOWI kr 205.60 kr 280.90 +37%
SalMar ASA SALM kr 580.50 kr 171.05 −71%
Charoen Pokphand Foods Public Company CPF 21.80 THB 55.71 THB +156%
United Plantations Berhad 2089 32.58 MYR 35.84 MYR +10%
Fujian Wanchen Food Group 300972 ¥155.26 ¥254.63 +64%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Xoma AB B · Fair Value
kr 0.2100 −60%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Xoma AB B Fair Value". https://www.fairvalue-calculator.com/stock/XOM-B

Frequently asked questions

Is Xoma AB B (XOM-B) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of kr 0.2100 versus a price of kr 0.5260, about −60% upside (overvalued).
What is the fair value of XOM-B?
Our model-based fair value for Xoma AB B is kr 0.2100 (as of Oct 4, 2026), built from audited fundamentals. The current price: kr 0.5260.
What is the quality score of XOM-B?
Xoma AB B has a Quality Score of 40/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Xoma AB B (XOM-B)?
Our model-based price target is the fair value of kr 0.2100 (as of Oct 4, 2026) from 1 valuation models. Cautious scenario kr 0.1400, optimistic scenario kr 0.2600. It is a calculation from audited fundamentals, not an analyst target.
What is the Xoma AB B stock forecast for 2026?
Our models put fair value at kr 0.2100, about −60% upside versus a price of kr 0.5260 (overvalued). Cautious scenario kr 0.1400, optimistic scenario kr 0.2600. The calculation is refreshed regularly with new filings.
What is the revenue of Xoma AB B (XOM-B)?
Xoma AB B reported trailing-twelve-month revenue of about 844K SEK (latest available figure, as of Oct 4, 2026).
What is the intrinsic value of Xoma AB B (XOM-B)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Xoma AB B it is kr 0.2100 per share (as of Oct 4, 2026), against a price of kr 0.5260. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Xoma AB B stock overvalued or undervalued in 2026?
As of Oct 4, 2026, XOM-B trades above its calculated fair value: price kr 0.5260, fair value kr 0.2100, a gap of about −60% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of XOM-B?
No. The price is what the market pays today (kr 0.5260); the fair value is what the company's own numbers justify (kr 0.2100). For Xoma AB B the two are kr 0.3160 per share apart. That gap is exactly why we show both numbers side by side.
How much is Xoma AB B worth?
The market values Xoma AB B at about 55.7M SEK (market capitalisation, as of Oct 4, 2026). Per share that is kr 0.5260; our models calculate a fair value of kr 0.2100 per share.
What do the bullish and bearish scenarios say about XOM-B?
Our models span a range for Xoma AB B: cautious scenario kr 0.1400, base kr 0.2100, optimistic kr 0.2600 per share (as of Oct 4, 2026, price kr 0.5260). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of XOM-B?
Xoma AB B trades at a price-to-earnings ratio of 26.1 (as of Oct 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 0.2100 is built from several models across several years. Other multiples: P/B 0.4, P/S 6.9.
How solid is the balance sheet of Xoma AB B (XOM-B)?
Balance-sheet figures for Xoma AB B (as of Oct 4, 2026): return on equity −110.9%. They feed the Quality Score of 40/100, which measures business quality independently of the share price.
How far is XOM-B from its 52-week high?
Xoma AB B trades at kr 0.5260, about 52% below its 52-week high of kr 1.10 and 136% above the low of kr 0.2230 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of kr 0.2100 is for.
Which stocks are comparable to Xoma AB B?
From the same area (Consumer Defensive) we also value Archer-Daniels-Midland Company, Muyuan Foods Group, Bunge Global SA, Tyson Foods, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Xoma AB B stock attractive at the current price?
The data as of Oct 4, 2026: price kr 0.5260, calculated fair value kr 0.2100 (−60%), Quality Score 40/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of XOM-B calculated?
We run Xoma AB B through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 0.2100, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Xoma AB B itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Xoma AB B (XOM-B)?
The closing price on Oct 2, 2026 was kr 0.5260. Our model-based fair value is kr 0.2100, about −60% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Xoma AB B right now?
The price sits above even our optimistic bull case (kr 0.2600). The favourable scenario is already priced in. Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (kr 0.1400 to kr 0.2600) leaves room in how you read the outcome.

Key figures of Xoma AB B

How large is the market capitalisation of Xoma AB B (XOM-B)?
The market capitalisation of Xoma AB B is 55.7M SEK (≈ $5.6M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Xoma AB B (XOM-B)?
The price-to-sales ratio of Xoma AB B is 50.6 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Xoma AB B (XOM-B)?
Earnings per share at Xoma AB B are kr −0.0900 (price ÷ EPS = P/E 26.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Xoma AB B (XOM-B)?
The return on equity (ROE) of Xoma AB B is −111% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Xoma AB B (XOM-B)?
On an EBIT basis the return on assets of Xoma AB B is −65.4% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Xoma AB B (XOM-B)?
The operating margin of Xoma AB B is −45,061% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Xoma AB B (XOM-B)?
Revenue at Xoma AB B is growing +726% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Xoma AB B (XOM-B) generate?
The free cash flow of Xoma AB B is −10.5M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Xoma AB B in the live analysis

One click puts Xoma AB B on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.